Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...

Continuing our series highlighting recent presentations from Nursing in Practice 365 events, diabetes specialist midwife ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

“Type 2 diabetes is a worldwide issue and continues to be difficult to treat effectively, despite the availability of ...

Newly prescribed medications during the follow-up included antihypertensive (10.1%), lipid-modifying (28.6%), weight-reducing (1.6%), and gastroprotective agents (6.3%). Overall, 36%, 42% ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.